You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Replacement therapy for
Primary immunodeficiency diseases (PID),
Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections,
Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
Immunomodulatory therapy for
Idiopathic thrombocytopenic purpura (ITP) in patients at high risk of bleeding or prior to surgery to correct the platelet count,
Guillain-Barr Syndrome (GBS),
Kawasaki disease,
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP),
Multifocal Motor Neuropathy (MMN),
Myasthenia Gravis (MG) exacerbations,
Lambert-Eaton Myasthenic Syndrome (LEMS),
Stiff Person Syndrome (SPS).
Replacement therapy for
Primary immunodeficiency diseases (PID),
Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections,
Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
Immunomodulatory therapy for
Idiopathic thrombocytopenic purpura (ITP) in patients at high risk of bleeding or prior to surgery to correct the platelet count,
Guillain-Barr Syndrome (GBS),
Kawasaki disease,
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP),
Multifocal Motor Neuropathy (MMN),
Myasthenia Gravis (MG) exacerbations,
Lambert-Eaton Myasthenic Syndrome (LEMS),
Stiff Person Syndrome (SPS).
Replacement therapy for
Primary immunodeficiency diseases (PID),
Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections,
Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
Immunomodulatory therapy for
Idiopathic thrombocytopenic purpura (ITP) in patients at high risk of bleeding or prior to surgery to correct the platelet count,
Guillain-Barr Syndrome (GBS),
Kawasaki disease,
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP),
Multifocal Motor Neuropathy (MMN),
Myasthenia Gravis (MG) exacerbations,
Lambert-Eaton Myasthenic Syndrome (LEMS),
Stiff Person Syndrome (SPS).
Replacement therapy for
Primary immunodeficiency diseases (PID),
Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections,
Symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
Immunomodulatory therapy for
Idiopathic thrombocytopenic purpura (ITP) in patients at high risk of bleeding or prior to surgery to correct the platelet count,
Guillain-Barr Syndrome (GBS),
Kawasaki disease,
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP),
Multifocal Motor Neuropathy (MMN),
Myasthenia Gravis (MG) exacerbations,
Lambert-Eaton Myasthenic Syndrome (LEMS),
Stiff Person Syndrome (SPS).
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
